Townsend & Associates Inc Buys 3,458 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Townsend & Associates Inc increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,080 shares of the pharmacy operator’s stock after acquiring an additional 3,458 shares during the quarter. Townsend & Associates Inc’s holdings in Walgreens Boots Alliance were worth $710,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp grew its position in shares of Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares during the last quarter. Two Sigma Advisers LP bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $24,226,000. Thompson Siegel & Walmsley LLC grew its position in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after purchasing an additional 817,762 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Down 3.3 %

Walgreens Boots Alliance stock opened at $10.16 on Friday. The firm has a market cap of $8.78 billion, a price-to-earnings ratio of -0.99, a PEG ratio of 1.31 and a beta of 0.65. The stock has a fifty day simple moving average of $10.37 and a two-hundred day simple moving average of $9.70. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the company earned $0.66 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research analyst reports. Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.63.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.